A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 6 - 17 |
| Updated: | 11/17/2018 |
| Start Date: | August 14, 2017 |
| End Date: | August 3, 2018 |
A Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity
This is a non-interventional study in children and adolescents (ages 6-17 years) with
attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in
glutamatergic signaling and neuronal connectivity. The screening in this study will be
conducted through a combination of online and site performed activities.
attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in
glutamatergic signaling and neuronal connectivity. The screening in this study will be
conducted through a combination of online and site performed activities.
Inclusion Criteria:
1. Parent/legally authorized representative (LAR) can speak and read English fluently,
have provided informed consent and agree to be contacted for an interventional study
prior to being genotyped.
2. Subject is 6 to 17 years of age (inclusive) at the time of informed consent.
3. Parent/LAR confirms that the subject has been diagnosed with or been told by a doctor
that their child has ADHD.
4. Parent/LAR confirms that the subject is not pregnant and/or breastfeeding.
Exclusion Criteria:
1. Parent/LAR confirms that the subject has been diagnosed with any of the following
conditions (aside from ADHD): conduct disorder, anxiety disorder, major depression,
autism spectrum disorder (ASD), bipolar disease, psychosis, hypertension, seizure
disorder, syncope, or other serious cardiac problems.
2. Aside from your child's current ADHD medication (if applicable), parent/LAR confirms
that the subject is currently taking any of the following medications:
antidepressants, anti-anxiety medications, anti-psychotics, and/or mood stabilizers.
3. Parent/LAR confirms that the subject has been genotyped previously in the
MDGN-NFC1-ADHD-001, MDGN-NFC1-ADHD-101 clinical study.
We found this trial at
1
site
Click here to add this to my saved trials
